CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
Michal Alon(Weizmann Institute of Science), Yardena Samuels(Weizmann Institute of Science)
Cited by 15
Related Papers
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
|Nature Communications|2020|156